Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson’s disease
Open accessAbstract
Objective: We aimed to identify key susceptibility gene targets in multiple datasets generated from postmortem brains and blood of Parkinson’s disease (PD) patients and healthy controls (HC). Methods: We performed a multitiered analysis to integrate the gene expression data using multiple-gene chips from 244 human postmortem tissues. We identified hub node genes in the highly PD-related consensus module by constructing protein–protein interaction (PPI) networks. Next, we validated the top four interacting genes in 238 subjects (90 sporadic PD, 125 HC and 23 Parkinson’s Plus Syndrome (PPS)). Utilizing multinomial logistic regression analysis (MLRA) and receiver operating characteristic (ROC), we analyzed the risk factors and diagnostic power for discriminating PD from HC and PPS. Results: We identified 1333 genes that were significantly different between PD and HCs based on seven microarray datasets. The identified MEturquoise module is related to synaptic vesicle trafficking (SVT) dysfunction in PD (P < 0.05), and PPI analysis revealed that SVT genes PPP2CA, SYNJ1, NSF and PPP3CB were the top four hub node genes in MEturquoise (P < 0.001). The levels of these four genes in PD postmortem brains were lower than those in HC brains. We found lower blood levels of PPP2CA, SYNJ1 and NSF in PD compared with HC, and lower SYNJ1 in PD compared with PPS (P < 0.05). SYNJ1, negatively correlated to PD severity, displayed an excellent power to discriminating PD from HC and PPS. Conclusions: This study highlights that SVT genes, especially SYNJ1, may be promising markers in discriminating PD from HCs and PPS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuroinflammation, including microglial proliferation, T cell infiltration, increased expression of inflammatory factors and glial cell activation, is an important pathology of Parkinson's disease.
“Neuroinflammation, including microglial proliferation, T cell infiltration, increased expression of inflammatory factors and glial cell activation, has been proven to be an important pathology of Parkinson's disease.145,146”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [145]
Cites
Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson’s Disease
Nguyen, M., Wong, Y. C., Ysselstein, D., Severino, A., & Krainc, D. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2018.11.001 · Cited by 323 · see citing works
Yamazaki, Y., Shinohara, M., Yamazaki, A., Ren, Y., Asmann, Y. W., Kanekiyo, T., & Bu, G. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313169 · Cited by 89 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281 · see citing works
Self-citationSigma-1 receptor: a potential therapeutic target for traumatic brain injury
Shi, M., Chen, F., Chen, Z., Yang, W., Yue, S., Zhang, J., & Chen, X. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.685201 · Cited by 58 · see citing works
Self-citationLiu, H., Huang, Z., Deng, B., Chang, Z., Yang, X., Guo, X., Yuan, F., Yang, Q., Wang, L., Zou, H., et al. (2023) · Aging and disease · doi:10.14336/ad.2022.0514 · Cited by 20 · see citing works
Self-citation
- Authors
- Gao, X., Huang, Z., Feng, C., Guan, C., Li, R., Xie, H., Chen, J., Li, M., Que, R., Deng, B., Cao, P., Li, M., Lu, J., Huang, Y., Li, M., Yang, W., Yang, X., Wen, C., Liang, X., Yang, Q., Chao, Y.-X., Chan, L.-L., Yenari, M. A., Jin, K., Chaudhuri, K. R., Zhang, J., Tan, E.-K., & Wang, Q.
- Affiliations
- Zhujiang Hospital (CN)
- University of California, Riverside (US)
- Guangzhou First People's Hospital (CN)
- Laboratory for Neuromodulation of Guangdong Second Provincial General Hospital, China
- Southern Medical University (CN)
- Department of Neurology, Zhujiang Hospital of Southern Medical University, China
- National University of Singapore (SG)
- Department of Neurology of National Neuroscience Institute, Singapore General Hospital, Duke-NUS Medical School
- San Francisco VA Medical Center (US)
- Department of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth, TX 76107, USA
- University of Washington (US)
- Singapore General Hospital (SG)
- Head of Department of Neurology, Zhujiang Hospital, Southern Medical University, China
- Corresponding author
- Gao, Xiaoya
- ORCID
- Venue
- Briefings in Bioinformatics
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-20
- Volume
- 22
- Issue
- 4
- ISSN
- 1467-5463 (ISSN-L)
- 1477-4054
- OpenAlex
- W3093667005
- Cited by
- 29
- References
- 2
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 9 · 2021: 9
- FWCI
- 2.38
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Briefings in Bioinformatics (publishedVersion)
- SSRN Electronic Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81873777, 81873776)
- National Key Research and Development Program of China (2017YFC1310200)
- Natural Science Foundations of Guangdong of China (2017A030311010)
- Initiated Foundation of Zhujiang Hospital (02020318005)
- Scientific Research Foundation of Guangzhou (201704030080)
- National Medical Research Council
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nuclear Receptors and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- Parkinson's disease, synaptic vesicle trafficking, SYNJ1, PPP2CA, NSF, PPP3CB, blood gene expression, protein-protein interaction network, diagnostic biomarkers, disease severity
- MeSH terms
- Autopsy, Female, Gene Expression Regulation, Humans, Male, Nerve Tissue Proteins, Parkinson Disease, Synaptic Vesicles, Biomarkers, Gene Expression Profiling, Gene Regulatory Networks, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review